Data in support of fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice

Autor: Du-Qiang Luo, Zhi-Qin Liu, Ting Liu, Chuan Chen, Ming-Yan Li, Zi-Yu Wang, Ruo-song Chen, Gui-xiang Wei, Xiao-yi Wang
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: Data in Brief, Vol 4, Iss C, Pp 159-161 (2015)
Druh dokumentu: article
ISSN: 2352-3409
DOI: 10.1016/j.dib.2015.03.006
Popis: This data article contains data related to the research article entitled “Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice” in the Toxicology and Applied Pharmacology [1]. Fumosorinone (FU) is a new inhibitor of protein phosphatase 1B inhibitor, which was isolated from insect pathogenic fungi Isaria fumosorosea. FU was found to inhibit PTP1B activity in our previous study [2]. PTP1B is the physiological antagonist of the insulin signalling pathway. Inhibition of PTP 1B may increase insulin sensitivity [3]. PTP1B has been considered promising as an insulin-sensitive drug target for the prevention and the treatment of insulin-based diseases [4]. We determined the effect of FU on the glucose consumption of IR HepG2 cells. FU caused significant enhancement in glucose consumption by insulin-resistant HepG2 cells compared with control cells.
Databáze: Directory of Open Access Journals